뇌수막염균 B 군(4CMenB) 감염병을 예방할 수 있는 영아 뇌수막염 B 백신. Infant meningitis B vaccine that can prevent meningococcal group B (4CMenB) infection Infant Meningitis B vaccine, which can prevent meningococcal group B (4CMenB) infection, is administered from 6 to 16 weeks of age. A study showed that when infants were vaccinated twice at 12 months of age and three times before 2 years of age, the effectiveness of the vaccine was 59%.

뇌수막염균 B 군(4CMenB) 감염병을 예방할 수 있는 영아 뇌수막염 B 백신.

Infant meningitis B vaccine that can prevent meningococcal group B (4CMenB) infection

Infant Meningitis B vaccine, which can prevent meningococcal group B (4CMenB) infection, is administered from 6 to 16 weeks of age.
A study showed that when infants were vaccinated twice at 12 months of age and three times before 2 years of age, the effectiveness of the vaccine was 59%.

뇌수막염균 B 군(4CMenB) 감염병을 예방 할수 있는 영아 뇌수막염 B 백신을 생후 6주~16주에서 부터

12 개월에 영아들에게 2회 접종하고 2세전에 3회 접종한 결과 59% 접종 효과가 좋았다는 연구가 나왔다.

JEJM, Pediatrics and adolescent Medicine, March 2020

www.koreapeditrics.com